INH AIRFLOW 250 is a prescription inhaler combining Fluticasone Propionate and Salmeterol Xinafoate , designed for the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This combination therapy provides anti-inflammatory and bronchodilator effects in a single, easy-to-use inhaler.
Fluticasone Propionate is a corticosteroid that reduces airway inflammation, swelling, and mucus production, while Salmeterol Xinafoate is a long-acting beta-agonist (LABA) that relaxes airway muscles to improve airflow and ease breathing. The synergistic action of these two ingredients makes INH AIRFLOW 250 effective in preventing asthma attacks, reducing COPD exacerbations, and enhancing overall lung function.
This inhaler is widely used in India to improve patient adherence, provide continuous symptom relief, and support long-term respiratory health.
Uses
INH AIRFLOW 250 is indicated for patients with moderate to severe respiratory conditions requiring maintenance therapy. Its primary uses include:
Asthma Management:
Reduces airway inflammation and prevents recurrent asthma attacks.
Helps improve lung function and overall quality of life.
Chronic Obstructive Pulmonary Disease (COPD):
Decreases bronchial inflammation and relaxes airway muscles.
Reduces frequency and severity of COPD flare-ups.
Exercise-Induced Bronchospasm:
Can prevent breathing difficulties triggered by physical activity in susceptible patients.
Long-Term Maintenance Therapy:
Ideal for patients requiring consistent, daily management of chronic respiratory conditions.
Helps maintain normal breathing patterns and reduce hospitalizations due to exacerbations.
By targeting both inflammation and bronchoconstriction, INH AIRFLOW 250 provides comprehensive control over respiratory symptoms.
Benefits
The combination of Fluticasone Propionate and Salmeterol Xinafoate offers multiple therapeutic benefits:
Reduces Airway Inflammation:
Fluticasone Propionate suppresses inflammation, swelling, and mucus accumulation in the airways.
Improves Breathing and Lung Function:
Salmeterol Xinafoate relaxes the muscles surrounding the airways, improving airflow and reducing wheezing, coughing, and shortness of breath.
Prevents Asthma Attacks and COPD Exacerbations:
Provides long-acting symptom control, reducing emergency hospital visits.
Continuous Symptom Relief:
Maintains airway openness and reduces daily discomfort for patients with chronic respiratory conditions.
Convenient and Easy-to-Use:
Metered-dose inhaler ensures accurate dosing, improving patient adherence and therapy effectiveness.
Synergistic Effect:
Combines anti-inflammatory and bronchodilator actions for optimal long-term control.
Enhances Quality of Life:
Patients experience improved exercise tolerance, reduced nighttime symptoms, and better overall respiratory health.
By addressing both inflammation and airway constriction, INH AIRFLOW 250 helps patients achieve sustained symptom control and long-term lung protection.
Dosage
The dosage of INH AIRFLOW 250 should be individualized based on patient age, severity of disease, and response to therapy. Always follow the instructions of a healthcare provider.
Standard Adult Dose:
One or two inhalations twice daily (morning and evening) is typical for maintenance therapy.
Shake the inhaler well before each use and exhale fully before inhaling the dose.
Administration Tips:
Place the mouthpiece in the mouth and inhale slowly while pressing the canister.
Hold breath for 5–10 seconds after inhalation for optimal deposition of the medication in the lungs.
Rinse mouth with water after each use to reduce risk of oral thrush and irritation.
Pediatric and Special Populations:
Dosage may vary in children or patients with severe respiratory compromise.
Consult a physician for tailored dosing recommendations.
Side Effects
INH AIRFLOW 250 is generally well-tolerated, but patients may experience some side effects. Awareness and monitoring are essential.
Common Side Effects:
Mild throat irritation or hoarseness
Coughing immediately after inhalation
Oral fungal infections (thrush)
Headache
Rare but Serious Side Effects:
Rapid heartbeat or palpitations
Severe allergic reactions (rash, swelling, difficulty breathing)
Paradoxical bronchospasm (worsening of breathing)
High blood sugar or adrenal suppression with long-term use
Patients should report severe or persistent symptoms to their healthcare provider immediately. Proper inhaler technique and oral rinsing help minimize many side effects.
Precautions and Warning
To ensure safe and effective use of INH AIRFLOW 250, consider the following precautions:
1. Medical History:
Inform your doctor if you have a history of heart disease, high blood pressure, diabetes, tuberculosis, or fungal infections.
2. Pregnancy and Lactation:
Consult a physician before use during pregnancy or breastfeeding. The inhaler should be used only if the potential benefits outweigh the risks.
3. Drug Interactions:
May interact with other corticosteroids, beta-agonists, antifungal medications, or certain HIV protease inhibitors.
Always inform your doctor about all concurrent medications.
4. Proper Inhaler Technique:
Correct inhaler use is essential for maximum benefit and minimizing side effects.
Patients should be trained by a healthcare professional on proper inhalation technique.
5. Monitoring:
Regular lung function tests and follow-up visits are recommended for patients on long-term therapy.
Watch for signs of worsening breathing or unusual side effects.
6. General Precautions:
Avoid abrupt discontinuation; therapy should be tapered under medical supervision if stopping is necessary.
Store in a cool, dry place away from direct sunlight.
Keep out of reach of children.
Conclusion
INH AIRFLOW 250 Fluticasone Propionate , Salmeterol Xinafoate is a highly effective combination inhaler for the management of chronic respiratory conditions such as asthma and COPD. By targeting both airway inflammation and bronchoconstriction, it provides continuous symptom relief, reduces exacerbations, and improves overall lung function.
The convenient metered-dose inhaler, combined with proper patient adherence, regular follow-ups, and healthy lifestyle measures, ensures optimal long-term respiratory health. Patients using INH AIRFLOW 250 experience improved quality of life, better exercise tolerance, and reduced dependence on emergency medications.
